The SP was 68c at Apr 2018. LOL.
On a serious note, I agree with your observation that other pot stocks, particularly CAN, do not seem to have done much in recent year. THC has accomplished a lot. My thoughts are that because our strategy is vertically integrated and strictly focused on fundamentals, it is hard to produce some headline-grabbing news, like an off-take agreement worth x million dollars.
Even after launching the actual products, we cannot say some ground-breaking numbers, because it really depends on the uptake of the patients and no middleman to guarantee revenue(again, like an off-take agreement). So no SP pumping as a result.
The only thing is to wait for the Quarterly in .... July.
- Forums
- ASX - By Stock
- EPN
- Ann: THC Global cannabis product available via prescription
Ann: THC Global cannabis product available via prescription, page-48
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online